Phase 1 Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Solid Tumors

NCT01765790 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

68

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Adenocarcinoma of the Colon or Rectum
Malignant Solid Tumors

Interventions

BIOLOGICAL: Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody
BIOLOGICAL: Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody

Sponsor

Baxalta now part of Shire